Inspired by animal immunity, Germany's Kupando raises €10 million for cancer therapy | EU-Startups
Schönefeld-based Kupando, a biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity and induces trained immunity for use in oncology and infectious diseases, has secu...
Source: EU-Startups
Schönefeld-based Kupando, a biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity and induces trained immunity for use in oncology and infectious diseases, has secured an additional €10 million in Series A financing – bringing their total Series A to €23 million. The investment was again led by Remiges Ventures, co-led by LifeCare […] The post Inspired by animal immunity, Germany’s Kupando raises €10 million for cancer therapy appeared first on EU-Startups.